Omicron News and Research

RSS
Maternal and neonatal outcomes during UK's SARS-CoV-2 Omicron wave

Maternal and neonatal outcomes during UK's SARS-CoV-2 Omicron wave

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Croup: A previously unrecognized complication of COVID-19 in young children

Croup: A previously unrecognized complication of COVID-19 in young children

Omicron emergence in South Africa associated with increased reinfection risk, analysis finds

Omicron emergence in South Africa associated with increased reinfection risk, analysis finds

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination

Neutralizing activity of therapeutic antibodies against clinical strains of BA.1 and BA.2 sub-lineages of the Omicron variant

Neutralizing activity of therapeutic antibodies against clinical strains of BA.1 and BA.2 sub-lineages of the Omicron variant

Study shows the mutations leading to omicron variant did not help virus escape recognition by T cells

Study shows the mutations leading to omicron variant did not help virus escape recognition by T cells

Exploring SARS-CoV-2 spike evolution in relation to sensitivity to antiviral restriction factors

Exploring SARS-CoV-2 spike evolution in relation to sensitivity to antiviral restriction factors

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Study finds fewer COVID-19 cases in schools with mandatory masking during Delta surge

Study finds fewer COVID-19 cases in schools with mandatory masking during Delta surge

Three vaccine doses are crucial to achieve effective protection against omicron

Three vaccine doses are crucial to achieve effective protection against omicron

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.